Home

CRAIG R STAPLETON

CIK 1207106 · See Remarks · last filed 2018-08-02

CRAIG R STAPLETON is a corporate insider who has filed 48 SEC Form 4 insider transactions across 3 companies since 2009. The most recent filing, for AVDL, was dated Aug 2, 2018. Across all open-market trades the lifetime net is +$2.2M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $6.0M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$5.99M

Companies

3

Total Filings

48

Lifetime Open-Market Net

$2.19M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Director 588,628 $21.64 $12.74M -$668.0K 14 2018-08-02
ANF Director 57,398 $104.35 $5.99M $942.2K 20 2017-06-16
AVADEL PHARMACEUTICALS PLC (FLML) Delisted Director 508,878 — — $1.92M 8 2017-01-03

Recent Filings

48 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-08-02 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Grant (A) +27,900 $0 EDGAR
2018-07-11 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Grant (A) +57,315 $0 EDGAR
2018-03-02 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Grant (A) — $0 EDGAR
2017-12-19 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Grant (A) +140,000 $1.21M EDGAR
2017-12-19 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Buy (P) +140,000 $1.21M EDGAR
2017-11-29 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Sell (S) −254,265 -$2.38M EDGAR
2017-09-14 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Buy (P) +20,000 $190.4K EDGAR
2017-06-30 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Grant (A) — $0 EDGAR
2017-06-16 ANF Exer (M) — $0 EDGAR
2017-05-22 AVADEL PHARMACEUTICALS PLC (AVDL) Delisted Buy (P) +31,013 $305.3K EDGAR
Showing 1–10 of 48
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.